(44) Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophagepolarization in tumour tissues(45) Ferumoxytol and CpG oligodeoxynucleotide 2395 synergistically enhance antitumor activity of macrophages against NSCLC with EGFR L858R/T790M mutation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.